HCA Healthcare (NYSE:HCA) Price Target Lowered to $387.00 at Barclays

HCA Healthcare (NYSE:HCA) had its price target trimmed by Barclays from $402.00 to $387.00 in a research report report published on Monday, MarketBeat reports. The firm currently has an equal weight rating on the stock.

Other analysts have also issued reports about the company. Wells Fargo & Company set a $369.00 price objective on HCA Healthcare in a research report on Monday, July 20th. Truist Financial set a $413.00 price target on shares of HCA Healthcare in a research report on Thursday, June 4th. Wall Street Zen lowered shares of HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Cantor Fitzgerald lowered their target price on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a report on Tuesday, July 7th. Finally, TD Cowen reduced their price target on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a research report on Monday, June 22nd. Fourteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $473.36.

HCA Healthcare Price Performance

HCA stock opened at $389.74 on Monday. The stock has a market capitalization of $86.46 billion, a PE ratio of 13.05, a price-to-earnings-growth ratio of 1.29 and a beta of 1.12. The company has a 50 day moving average price of $386.30 and a 200 day moving average price of $452.90. HCA Healthcare has a fifty-two week low of $331.61 and a fifty-two week high of $556.52.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. During the same period last year, the firm earned $6.84 EPS. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. As a group, equities analysts expect that HCA Healthcare will post 29.19 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be issued a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare’s payout ratio is 10.45%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in HCA. Sumitomo Life Insurance Co. raised its position in shares of HCA Healthcare by 1.0% during the fourth quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock worth $946,000 after purchasing an additional 20 shares during the period. MJP Associates Inc. ADV increased its stake in HCA Healthcare by 2.9% during the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after purchasing an additional 21 shares in the last quarter. Cary Street Partners Investment Advisory LLC lifted its stake in HCA Healthcare by 7.5% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after buying an additional 21 shares in the last quarter. Anchyra Partners LLC increased its position in shares of HCA Healthcare by 3.7% during the first quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock worth $278,000 after acquiring an additional 21 shares in the last quarter. Finally, Plato Investment Management Ltd raised its holdings in shares of HCA Healthcare by 0.6% during the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after acquiring an additional 22 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Q2 results exceeded expectations. HCA reported adjusted earnings of $7.59 per share versus the $7.56 consensus estimate, while revenue rose 8.7% year over year to $20.23 billion, topping forecasts of $19.76 billion. The earnings beat and continued revenue growth are supporting investor sentiment. HCA Healthcare’s Q2 CY2026 sales top estimates
• Positive Sentiment: Analysts remain broadly constructive despite lower targets. Truist, Oppenheimer and KeyCorp cut their price targets but retained buy, outperform or overweight ratings. RBC also reaffirmed its outperform rating with a $435 target, indicating that analysts still see upside from current levels. HCA Healthcare Analysts Slash Their Forecasts After Q2 Results
• Neutral Sentiment: HCA declared a quarterly dividend of $0.78 per share. The dividend is payable September 30 to shareholders of record September 16 and carries an indicated yield of approximately 0.8%, providing modest shareholder income.
• Neutral Sentiment: Leadership change at two Tampa hospitals. HCA promoted a new chief executive officer for the facilities, a routine management update with limited immediate financial impact. HCA promotes new CEO of 2 Tampa hospitals
• Negative Sentiment: Uninsured Affordable Care Act patients are a concern. Nearly all of HCA’s ACA exchange patients reportedly lacked insurance coverage during the quarter, highlighting reimbursement and bad-debt risks that could weigh on margins and future earnings.
• Negative Sentiment: Multiple analysts reduced their forecasts after the earnings release. Barclays moved to equal weight with a $387 target, while Baird maintained a neutral rating and lowered its target to $393. The widespread target reductions suggest expectations for HCA’s future growth and profitability have moderated.
• Negative Sentiment: Mission Health compliance concerns remain unresolved. Reports of a third consecutive year of compliance issues add legal, regulatory and reputational risk for HCA. HCA Healthcare faces third straight year of Mission Health compliance concerns

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.